Goodwin advised Gandeeva on the deal. Gandeeva announced its Series A funding led by Lux Capital and Leaps by Bayer, with participation from Obvious Ventures, Amgen Ventures,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised CardioFocus, Inc. on the deal. CardioFocus, Inc. announced its licensing and distribution agreement with China Grand Pharmaceutical (Grand Pharma). The agreement provides a license...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Lyra Therapeutics, Inc. on the deal. Lyra Therapeutics, Inc. (Nasdaq: LYRA) announced its strategic partnership and exclusive license agreement with LianBio for the...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Envisagenics on the deal. Envisagenics announced its collaboration with Biogen Inc. (Nasdaq: BIIB) to advance ribonucleic acid (RNA) splicing research within central nervous...
You must be a Standard 1 Year member to access this content.
